Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.39%

Biogen Idec Inc. (BIIB)

-NasdaqGS
329.83 Down 4.56(1.36%) Aug 1, 3:59PM EDT
|After Hours : 329.83 0.00 (0.00%) Aug 1, 6:05PM EDT
Prev Close:334.39
Open:332.93
Bid:326.00 x 200
Ask:330.00 x 200
1y Target Est:369.42
Beta:1.23
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:325.85 - 337.82
52wk Range:203.55 - 358.89
Volume:1,319,275
Avg Vol (3m):1,166,620
Market Cap:77.89B
P/E (ttm):41.02
EPS (ttm):8.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 1.36%77.89B
PFEUp 0.56%184.09B

Key Statistics

Forward P/E (1 yr):20.32
P/S (ttm):9.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.14
Quarterly EPS Est (Sep-14) :3.48
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.26

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis (MS), neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback